Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces-Reference-Cited by-同舟云学术

Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces

Published:2010-07-17 Issue:1 Volume:10 Page:
ISSN:1472-6963
Container-title:BMC Health Services Research
language:en
Short-container-title:BMC Health Serv Res

Author:

Chen Wen,Tang Shenglan,Sun Jing,Ross-Degnan Dennis,Wagner Anita K

Publisher

Springer Science and Business Media LLC

Subject

Health Policy

Link

http://link.springer.com/article/10.1186/1472-6963-10-211/fulltext.html

Reference21 articles.

1. China National Health Economics Institute: China National Health Accounts Report. 2008, Beijing

2. Jacobzone S: Pharmaceutical policies in OECD countries: Reconciling social and industrial goals. Paris. Labour Market and Social Policy. 2004, Occasional Papers No. 40

3. Ye L, Chen W, Ying X, Liu B, Hu S: The problems and causes of essential medicines production, distribution and use. Chinese Health Resources. 2008, 11: 51-53.

4. Yip W, Eggleston K: Addressing government and market failures with payment incentives: hospital reimbursement reform in Hainan, China. Social Science & Medicine. 2004, 58: 267-277.

5. Eggleston K, Li L, Meng Q, Lindelow M, Wagstaff A: Health service delivery in China: A literature review. Health Economics. 2008, 17: 149-165. 10.1002/hec.1306.

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of China's zero markup drug policy on drug costs for managing Parkinson's disease and its complications: an interrupted time series analysis;Frontiers in Public Health;2023-05-09

2. Identifying key influences on antibiotic use in China: a systematic scoping review and narrative synthesis;BMJ Open;2022-03

3. Longitudinal Association of Salaries for Medical Staff With Medical Service Utilization and Expenditure in China, 2007–2016;Frontiers in Public Health;2021-12-10

4. The impact of policy on availability and price of low‐price medicines in public healthcare institutions: A retrospective survey in Nanjing, China;The International Journal of Health Planning and Management;2021-11-30

5. Did the universal zero-markup drug policy lower healthcare expenditures? Evidence from Changde, China;BMC Health Services Research;2021-11-06